MIRAmedtech UG is a private German company that manufactures aesthetic medical devices. It is part of the German CARISMED GROUP, which also includes U.S.-based eMIRAmed. MIRApeel, an associated product line, was founded in 2017 and has approximately 1-10 employees. MIRAmedtech UG's headquarters are located in Königsbach-Stein, Germany.
The company invents and manufactures the MIRApeel™ system, a comprehensive cosmetic device designed for 3D Skin Desquamation and Fractional Transbrasion™ treatments. This system includes patented MIRAbrasor™ handpieces, MIRArollers™ (non-invasive micro-protrusion attachments), and MIRAjolie™ high-performance cosmetic serums. The MIRApeel™ system is FDA cleared and CE MARK approved.
MIRAmedtech UG is primarily a defendant in patent litigation. The company has been involved in one tracked case, appearing solely as a defendant. This indicates a posture of an operating company defending against patent infringement claims. The case was filed in the U.S. District Court for the Central District of California.
The company's sole tracked litigation, HydraFacial LLC et al. v. MIRAmedtech SP. Z.O.O. et al. (8:24-cv-01865), resulted in a judgment in favor of HydraFacial LLC and Edge Systems, LLC. The court issued a permanent injunction prohibiting MIRAmedtech UG and co-defendant MIRAmedtech SP. Z.O.O. from making, using, selling, offering for sale, or importing MIRApeel systems into the United States, as well as infringing U.S. Patent Nos. 9,550,052; 11,446,477; 11,865,287; and 12,053,607. The resolution of this case was notably swift, taking 207 days, and MIRAmedtech UG was also found in default in a related U.S. International Trade Commission (ITC) investigation concerning certain hydrodermabrasion systems.